Remove Blogging Remove Invest Remove San Diego Remove Venture Capital

33 Tech Startups Make San Diego Venture Group “Cool Companies” List

Xconomy

In the eyes of the San Diego Venture Group, the key element is readiness for venture capital backing. What does it take for a tech startup to be considered “cool?”

San Diego Startup Raises $2.3M to Advance Enzymatic DNA Synthesis

Xconomy

Molecular Assemblies , a San Diego startup developing a new enzymatic method for synthesizing DNA, said today it has raised $2.3 million in a seed financing round.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

$100M Round Turns San Diego’s Seismic into Region’s Newest Unicorn

Xconomy

The venture investment, which the San Diego startup announced Tuesday, is one of only a few so-called mega-rounds—$100 million or more—recorded this year in the region. (In Rowe Price Tech Uber unicorn VC Venture Capital Virtual InstrumentsSeismic, an enterprise software company with ambitious growth plans, has raised $100 million in a Series E financing and added Microsoft chairman John W. Thompson to its board of directors.

U.S. Venture Capital Deals on Pace to Exceed $100B in 2018

Xconomy

Once considered a passing phase, the concentration of capital into fewer, larger venture capital deals appears to be the new normal. Fueled by so-called mega-funds, investment in U.S.-based

San Diego VC Funding Hits $547.2M in Q1; Ideaya Leads Top 10 Deals

Xconomy

Venture capital investors sank $547.2 million into 37 startup companies throughout San Diego County during the first three months of 2018, maintaining roughly the same level of venture funding seen in recent quarters, according to the Venture Monitor Report. The amount of capital invested in the San Diego area was up slightly from the $541.2 million invested in the first quarter last year.

Record Exit Value for VC-Backed Startups Could Fuel Investment

Xconomy

More than a third of the companies that went public in the first half of this year were backed by venture capital. That, plus robust merger and acquisition activity, set a record for venture-backed exit value—$165.2

Xconomy Guide to Best Sessions at Startup Week San Diego

Xconomy

Startup Week San Diego, like a lot of other places that host similar events, has been billed as a weeklong celebration of entrepreneurship. This year’s Startup Week also has added five new tracks intended to highlight San Diego’s strengths as a startup ecosystem.

San Diego VC Funding at $426.6M in Third Quarter; Plus Top 10 Deals

Xconomy

The San Diego artificial intelligence company Brain Corp. topped the chart for raising the most venture capital in San Diego during the third quarter that ended September 30, according to Venture Monitor data released Tuesday. Altogether, venture firms invested. As Xconomy reported in July, Brain Corp. raised $114 million in a Series C funding round led by Softbank’s new $100 billion Vision Fund.

San Diego Startups Raise $287M in Third Quarter, and Top 10 Deals

Xconomy

Venture Capital investments in San Diego startups fell by roughly a third during the three months that ended September 30, according to data released recently by Seattle-based PitchBook and the National Venture Capital Association. VC firms invested $280.6 million in 49 startups in San Diego County during the third quarter, according to a breakout of data provided by PitchBook as part of the inaugural “Venture Monitor” report.

VC Trends in 2019: More Money, Fewer Deals But Women Still Get Less

Xconomy

If you’ve been following venture capital trends, what you expected to happen in the first quarter of 2019 did: More money is being invested in fewer deals, and women founders still are getting less of it than men. Venture firms sent $32.6

Dell Technologies Goes Public About $100M Venture Capital Arm

Xconomy

Austin —Dell Technologies is publicly unveiling a venture capital investment arm that has been quietly investing in startups since the operation was run by EMC, the data storage giant that Dell agreed to acquire for $67 billion in 2015. Called Dell Technologies Capital, the investment arm plans to provide funding to about 20 startups this year, Scott Darling, president of group, told Bloomberg , which first reported the news this morning.

Q2 VC Funding Soars in San Diego (After Revisions), and Top 10 Deals

Xconomy

After the national MoneyTree Report was released last week, PricewaterhouseCoopers partner Ryan Spencer said he spent time on a call with Thomson Reuters, which provides the raw data, trying to figure out a change in the numbers for venture capital activity in San Diego.

First-Quarter Venture Funding Slumps in San Diego, and Top 10 Deals

Xconomy

Thirty-seven venture-backed companies in the San Diego area collected almost $350 million in new funding during the first three months of 2017, according to data released this week as part of the latest Venture Monitor report from the National Venture Capital Association and Seattle-based PitchBook. million that VCs invested in San Diego startups in the same quarter in 2016, and off nearly 17 percent from the $420.3 billion invested.

Big Deals, Life Sciences Push U.S. VC in 2018 to Dot-Com Boom Levels

Xconomy

Venture capital investments rose in 2018 to levels not seen since the heady days of 2000, the last year U.S. That was about 500 fewer deals than in the year prior, but the total amount invested increased by $47.9

Latest Data Show Venture Capital Industry on Pins and Needles

Xconomy

venture industry is also exhibiting some fatigue as we finish the 88th month since the last recession. According to the National Venture Capital Association and PitchBook , this past quarter $15 billion was invested in 1,810 deals , which compares unfavorably to both the prior quarter ($22.1

Former Biotech VC Steven Burrill Draws 30-Month Prison Term for Fraud

Xconomy

Steven Burrill, once a noted biotech investment fund founder, sought-after conference speaker, and life sciences publisher, was sentenced Wednesday to serve 30 months in federal prison for defrauding his investors and evading taxes.

Despite Low Crop Prices, Corporate and VC Agtech Investments Soar

Xconomy

Prices for agricultural commodities such as corn, soy, and wheat are at their lowest levels in years, but investment in agricultural technology has never been better. They also queried 15 VC firms. Venture capitalists are similarly cautious.

Biopharma Execs Remain Optimistic Despite Political Headwinds

Xconomy

These are among the major findings of a survey of 500 industry leaders and investors conducted by investment bank Jefferies. Life Sciences london M&A Politics Private Equity uk VC

RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures

Xconomy

RiverVest Venture Partners, a St. Louis, MO-based venture capital firm with additional offices in San Diego, CA, and Cleveland, OH, has raised $184.4 million for its fourth fund dedicated to investing in healthcare companies.

Invest 109

New VC Firm Blueprint Equity Puts $6M into Florida Software Company

Xconomy

A new venture capital firm, which in November marked its launch by raising a $53 million-plus fund to invest in startups, has made its first investment. Lewis was mostly recently with San.

Retro: My Favorite Blog Post on Raising VC

Both Sides of the Table

On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out. I had kept a personal blog for more than a year and was new at keeping a professional blog. Remember, I was new to professional blogging.

VC Funding Surges in Fewer Deals in Third Quarter, and Top 10 Deals

Xconomy

“More dollars, fewer deals” has been a prevailing trend in venture funding over the past couple of years, and it was evident again in the three months that ended September 30, according to the latest Venture Monitor report. Venture firms invested $21.5

VC Activity Continues Slowdown in Fourth Quarter, and Top 10 Deals

Xconomy

Venture capital firms didn’t exactly take their foot off the accelerator, but the pace of VC investments continued to weaken in the three months that ended in December, extending a slowdown that began in July, according to two venture reports issued today.

Beyond Meat’s IPO Bags $241M to Make Plant-Based Burgers Mainstream

Xconomy

deals DNS Venture Partners Ethan Brown Impossible Foods investing IPO Kleiner Perkins Caufield & Byers Kroger Obvious Ventures startups TGI Friday's VC Venture Capital Wegmans Whole Foods Market xperience

TP Therapeutics Names New CEO, Gets $80M More for Cancer Drug Push

Xconomy

The San Diego-based biotech, which is developing targeted cancer drugs for people whose tumors resist other precision therapies, announced the changes Friday.

Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston

Xconomy

We at Xconomy are excited to announce that we are honoring Mark Levin, co-founder and partner at Third Rock Ventures, with our 2019 Lifetime Achievement Award in Boston. Levin built Millennium Pharmaceuticals—inspiring a generation of future executives/entrepreneurs along the way—and also helped reinvent the venture capital market for early stage biotechs by founding Third Rock, where his work has helped bring a slew of important new companies and new drugs to market.

At Venture Summit, 3 Takeaways For Entrepreneurs From True Ventures’ Phil Black

Xconomy

No one would argue that San Diego is overflowing with venture capitalists in the way, say, the San Francisco Bay Area is. Venture Summit —an annual gathering of local founders seeking financing and venture investors, primarily from outside San Diego, on the hunt for companies to back—was first organized by the San Diego Venture Group (SDVG) 17 years ago.

Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More

Xconomy

The coronavirus pandemic has shaken the global economy, but three life sciences venture capital firms this week announced new funds totaling nearly $3 billion. ARCH Venture Partners led the pack, adding two funds totaling $1.46

Tool 74

Billie, Subscription Shaving Products Service for Women, Raises $25M

Xconomy

The New York-based startup said Tuesday that the new funding round, which is being led by Goldman Sachs Private Capital Investing group, brings its total investment to $35 million.

Norwest VC Eyes Waves of Change in A.I., Marketing, Cloud for 2019

Xconomy

Venture capital firms invest in potentially disruptive technologies with the hope of profit, then keep watch for further advances that could overtake their existing portfolio companies. Scott Beechuk, a partner at Norwest Venture Partners , is one of the tech industry observers invited by Xconomy to look back at the technology developments of 2018, and also forecast some trends he expects to see in 2019.

Guide 57

To Help Boost Female-led Startups, More Women Join Investor Ranks

Xconomy

Houston —Men have long leveraged their networks to succeed in business, and the tech industry has been no exception. Women, finding themselves outside of the club, are now creating their own networks to do the same. Katelyn O’Shaughnessy already had a solid track record, selling TripScope , a travel startup she co-founded in 2013, to Travefy two years ago.

Help 87

Finding True Love Can Be Ruff, But This Startup Could Have Your Match

Xconomy

profile people pets rehoming shelter Software Staffordshire terrier Startup Tama Lundquist Tech Texas VC Venture Capital xperienceToo many people treat pet adoption like a one-night stand.

As Castle Bio Jumps on IPO Train, Industry Trends Suggest Slowdown

Xconomy

Castle Biosciences is joining the public markets through a $64 million IPO that will support cancer tests that help doctors make treatment decisions. On Wednesday evening, Castle priced its offering of 4 million shares at $16 apiece, which was the high end of its targeted price range.

Flagship Adds $1.1B for New Meds, More AI, & “Health Security”

Xconomy

On Thursday the Cambridge, MA-based venture capital firm, best known for starting and spinning out biotechs, announced it had added $1.1

Graphcore Scores $200M to Scale Up A.I. Chip Production

Xconomy

The Bristol, UK-based startup, founded in 2016, has now secured a total of more than $300 million in financing from venture capital firms and other investors including Microsoft and the corporate venture arms of BMW and Dell Technologies. One of the leading contenders in the A.I.

CEOs of Women’s Health Companies Fight to Open Investment Floodgates

Xconomy

EvoFem (NASDAQ: EVFM )—and the rest of the women’s health sector—will know by midyear whether the product will be approved, making the San Diego companies one of the few biotechs to commercialize a novel prescription women’s health product in recent years.

Black Fellowship Students Headed From HBCUs to VC Boardrooms

Xconomy

In mid-October, eleven college students will be flying to California for an opportunity that would be the envy of any Ivy League MBA candidate—they’ll meet the venture capital firm partners who will personally mentor them throughout the school year.

VC “Self-Correction” Continues in Second Quarter, and Top 10 Deals

Xconomy

venture capital investments are showing more signs of returning to steady levels. billion into 1,958 companies in the second quarter, according to data from the quarterly Venture Monitor report from Seattle-based PitchBook and the National Venture Capital Association (NVCA).

Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More

Xconomy

Merger merger and acquisition mice Modis Therapeutics Monica Forbes Multiple Myeloma Multiple Sclerosis neary opioid opioid cris Otezla passed away PCSK9 pharma PHASE # Praluent price Purdue Pharma Regeneron Pharmaceuticals Repatha Rhonda Chicko Richard Fitzgerald Richard Sackler RIP Rise Rodger Currie Rova-T Scholar Rock Scott Gottlieb SEngine PRecision Medicines Sesen Bio Stemcentryx Studies Symdeko Thomas Neff Tom Nearty Trial VC Venture Capital Vertex Zogenix

With $42M, Ex-Ignyta CEO Aims At Cancer Again With Startup, Erasca

Xconomy

Ignyta’s former co-founder and head executive has co-founded another biotech in San Diego, Erasca, which also wants to make new cancer therapies. A year after steering cancer drug developer Ignyta into a $1.7 billion sale to Roche , Jonathan Lim is back at it again.

Sales 91

Bio-JPM Roundup: Lilly Buys Loxo, Sage’s Stock Soars, ALS Cash & More

Xconomy

Morgan Healthcare Conference, one of the biggest gatherings for the biopharmaceutical industry, kicked off today in San Francisco, and many companies, whether they’re speaking at the event or not, use this time to get their news out. The flow of biotech news is particularly heavy today, and for good reason. The annual J.P.

News 70

Ventus Launches With $60M to Shine Light on Innate Immune System Drugs

Xconomy

Jude Children's Research Hospital startups Teva Pharmaceutical University of California at Berkeley Venture Capital Ventus Therapeutics Versant Ventures Yale UniversityThe innate immune system has become a hot area for drug development, and for good reason.

Tool 73

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

Xconomy

The Boston company, which counts diabetes drug giants Eli Lilly (NYSE: LLY ) and Novo Nordisk (NYSE: NVO ) among its investors and partners, says the capital will support Phase 3 studies of its device this year, and if all goes well, an application for FDA approval.

Study 94